# Role of glymphatic system function in cognitive dysfunction among patients with bipolar disorder

**Authors:** Mu-Hong Chen, Ying-Jay Liou, Ju-Wei Hsu, Shih-Jen Tsai, Chiung-Chih Chang, Ya-Mei Bai

PMC · DOI: 10.1093/ijnp/pyaf069 · International Journal of Neuropsychopharmacology · 2026-02-02

## TL;DR

This study found that impaired glymphatic system function is linked to cognitive issues in bipolar disorder patients, but not in healthy individuals.

## Contribution

The study identifies a specific link between glymphatic dysfunction and cognitive deficits in bipolar disorder.

## Key findings

- Lower ALPS index levels were associated with worse cognitive performance in bipolar disorder patients.
- Glymphatic dysfunction appears to contribute to cognitive impairment in bipolar disorder.
- No difference in ALPS index levels was found between bipolar patients and healthy controls.

## Abstract

Increasing evidence has suggested a potential role of glymphatic system function in the pathomechanisms underlying mood disorders and related cognitive impairment. However, this association in bipolar disorder remained unclear.

In all, 185 patients (mean age ~ 30 years) with bipolar disorder and 95 healthy individuals were enrolled for the assessment of the go/no-go task and the digit symbol substitution test (DSST). The Analysis Along the Perivascular Space (ALPS) index, an indicator of glymphatic system activity, was measured using diffusion tensor imaging within diffusion magnetic resonance imaging. All participants were divided into two subgroups (< vs. ≥ mean level) based on the mean ALPS index level. Additionally, participants were further categorized into quartiles based on ALPS index levels, ranging from Q1 (highest) to Q4 (lowest).

Generalized linear model, after adjusting for age, sex, education years, and clinical symptoms, found no difference in the ALPS index levels between patients and controls. Patients with lower ALPS index levels—that is, those with values below the mean or in the lowest quartile (Q4)—performed the worst on the DSST and the go/no-go task.

Glymphatic system dysfunction appeared to play a critical role in cognitive impairment among patients with bipolar disorder, but not in healthy individuals. Further research is warranted to clarify the specific pathomechanisms underlying this bipolar disorder–specific association between glymphatic system dysfunction and cognitive deficits.

## Linked entities

- **Diseases:** bipolar disorder (MONDO:0004985)

## Full-text entities

- **Genes:** Aqp4 (aquaporin 4) [NCBI Gene 11829] {aka WCH4}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Diseases:** mood disorders (MESH:D019964), neurovascular diseases (MESH:D013901), amyotrophic lateral sclerosis (MESH:D000690), glymphatic dysfunction (MESH:D006331), Parkinson's disease (MESH:D010300), insomnia (MESH:D007319), sleep disruption (MESH:D019958), sleep dysregulation (MESH:D021081), sleep disturbance (MESH:D012893), Glymphatic system dysfunction (MESH:D007154), Bipolar Disorder (MESH:D001714), Cognitive Dysfunction (MESH:D003072), Alzheimer's disease (MESH:D000544), Depression (MESH:D003866), deficits in inhibitory control and executive functioning (MESH:D007174), epilepsy (MESH:D004827), deficits in working memory, attention, inhibitory control, and executive function (MESH:D001289), neurodevelopmental disorders (MESH:D002658), neurotoxic (MESH:D020258), type 2 diabetes mellitus (MESH:D003924), neurodegenerative disorders (MESH:D019636), ALPS (MESH:D054973), Mental Disorders (MESH:D001523), neuroinflammation (MESH:D000090862), alcohol and substance use disorders (MESH:D000437), schizophrenia (MESH:D012559), autoimmune diseases (MESH:D001327)
- **Chemicals:** fluoxetine (MESH:D005473)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** V114C, V113C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12862977/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12862977/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12862977/full.md

---
Source: https://tomesphere.com/paper/PMC12862977